Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Clin Transl Gastroenterol ; 9(4): 145, 2018 04 25.
Article in English | MEDLINE | ID: mdl-29691365

ABSTRACT

OBJECTIVES: Inflammation and inflammatory conditions have been associated with pancreatic cancer risk and progression in a number of clinical, epidemiological, and animal model studies. The goal of the present study is to identify plasma markers of inflammation associated with survival of pancreatic cancer patients, and assess their joint contribution to patient outcome. METHODS: We measured circulating levels of four established markers of inflammation (C-reactive protein (CRP), interleukin-6 (IL-6), soluble tumor necrosis factor receptor type II (sTNF-RII), and macrophage inhibitory cytokine-1 (MIC-1)) in 446 patients enrolled in an ongoing prospective clinic-based study. Hazard ratios (HRs) and 95% confidence intervals (CI) for death were estimated using multivariate Cox proportional hazards models. RESULTS: Overall mortality was significantly increased in patients in the top quartile of CRP (HR = 2.52, 95% CI: 1.82-3.49), IL-6 (HR = 2.78, 95% CI: 2.03-3.81), sTNF-RII (HR = 2.00, 95% CI: 1.46-2.72), and MIC-1 (HR = 2.53, 95% CI: 1.83-3.50), compared to those in the bottom quartile (P-trend <0.0001 for all four comparisons). Furthermore, patients with higher circulating concentrations of all four cytokines had a median survival of 3.7 months; whereas, those with lower levels had a median survival of 19.2 months (HR = 4.55, 95% CI: 2.87-7.20, P-trend <0.0001). CONCLUSION: Individual elevated plasma inflammatory cytokines are associated with significant and dramatic reductions in pancreatic cancer patient survival. Furthermore, we observed an independent combined effect of those cytokines on patient survival, suggesting that multiple inflammatory pathways are likely involved in PDAC progression. Future research efforts to target the inflammatory state using combination strategies in pancreatic cancer patients are warranted.


Subject(s)
Carcinoma, Pancreatic Ductal/blood , Carcinoma, Pancreatic Ductal/mortality , Cytokines/blood , Inflammation/blood , Pancreatic Neoplasms/blood , Pancreatic Neoplasms/mortality , Aged , Biomarkers/blood , Disease Progression , Female , Humans , Male , Middle Aged , Prospective Studies , Risk Factors
2.
Clin Chem ; 36(2): 351-4, 1990 Feb.
Article in English | MEDLINE | ID: mdl-2302781

ABSTRACT

We investigated the suppressive effects of phosphate on calcium determinations with lanthanum-air/acetylene and potassium-nitrous oxide/acetylene methods, and we evaluated the ability of these methods to meet the suggested analytical goals for urine samples. The 20 g/L La-air/acetylene method was the most nearly accurate for predicting the actual calcium concentrations (t-test value = -0.042), followed by the 2 g/L K-nitrous oxide/acetylene method (t-test value = 0.450), 10 g/L La-air/acetylene (t-test value = -0.733), and finally 5 g/L La-air/acetylene (t-test value = -2.446). The dilution used significantly influences the apparent calcium concentration measured with the La-air/acetylene methods.


Subject(s)
Calcium/urine , Phosphates/urine , Animals , Calcium/standards , Cats , Chemistry, Clinical/standards , False Negative Reactions , Humans , Phosphates/standards , Spectrophotometry, Atomic/methods
SELECTION OF CITATIONS
SEARCH DETAIL